Autres langues Strides Pharma Science Limited Bombay S.E.

Actions

532531

INE939A01011

Marché Fermé - Bombay S.E. Autres places de cotation 12:00:49 17/05/2024			Varia. 5j.	Varia. 1 janv.
869,6 ^INR	-0,25%		+3,03%	+34,11%

10/05	Les poids lourds du marché soutiennent les actions indiennes pour terminer la semaine en hausse	MT
10/05	Strides Pharma Arm obtient l'approbation de la FDA américaine pour un médicament générique contre l'hypocalcémie	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Strides Pharma Science : Intimation of Board Meeting scheduled on May 22, 2024	14/05
Market Heavyweights Lifts Indian Equities to End Week Higher	10/05
Strides Pharma Arm Gets US FDA's Approval for Generic Drug for Hypocalcemia	10/05
Strides Pharma Science Limited Approves Appointment of Ameet P Hariani as Independent Director	30/04
Strides Pharma Science Gets US FDA Nod for Fluoxetine Tabs	09/04
Strides Pharma Science Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	30/01
Strides Pharma Science Arm Gets US FDA Nod for Pregabalin Capsules	26/01
Strides Pharma Science's Swiss Unit to Sell Entire Stake in Eris Pharma	11/01
Strides Pharma Science Arm Acquires Additional 25% Stake in Neviton Softech	08/01
Strides Pharma Science Acquires Minority Stake in Two Renewable Energy Companies	02/01
Strides Pharma Science Subsidiary Secures Credit Facility Worth INR319 Million	21/12
Amneal Expands Portfolio with Addition of Icosapent Ethyl Acid Soft Gel Capsules	04/12
India's Nifty set to open at new record highs for second session in a row	04/12
Amneal Expands Portfolio with Addition of Icosapent Ethyl Acid Soft Gel Capsules	01/12
Strides Pharma Unit Gets US FDA Approval for Generic Bowel Prep Kit Solution	23/11
Strides Pharma Global Pte. Limited Receives USFDA Approval for Generic Suprep®? Bowel Prep Kit	23/11
Strides Pharma Science Arm Gets US FDA's Nod for Generic Seizure Treatment	21/11
First African-Manufactured Combination Therapy For Seasonal Malaria Chemoprevention Receives WHO Prequalification [press release]	06/11
Strides Pharma Science Appoints COO	31/10/23
Strides Pharma Science Limited Announces Change in Management	30/10/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Strides Pharma Science Limited Bombay S.E.

Actions

532531

INE939A01011

Autres langues

Filtres